Author

K. de Joode

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. A. M. van der Veldt· 1 shared A. Beeker· 1 shared E. Cuppen· 1 shared G. J. L. H. van Leenders· 1 shared H. J. G. van de Werken· 1 shared H. M. Westgeest· 1 shared J. M. van Rooijen· 1 shared L. V. Beerepoot· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. M. van der Veldt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genomic and transcriptomic landscape of advanced renal cell cancer to individualize treatment strategy

K. de Joode, W. S. van de Geer, G. J. L. H. van Leenders, P. Hamberg, H. M. Westgeest, A. Beeker, S. F. Oosting, J. M. van Rooijen, L. V. Beerepoot, M. Labots, R. H. J. Mathijssen, M. P. Lolkema, E. Cuppen, S. Sleijfer, H. J. G. van de Werken, A. A. M. van der Veldt

This study uses genomic and transcriptomic data from advanced renal cell cancer patients to identify actionable mutations and immune signatures to guide personalized treatment strategies.

Scientific Reports · Jul 3, 2023Peer-reviewedCancer Biology